Daiichi Sankyo Co Ltd., Eli Lilly and Company (JOBS) Win European Approval for Prasugrel

February 23, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BOSTON, Feb 23 (Reuters) - Eli Lilly & Co and Japan's Daiichi Sankyo Co said on Monday that they had won European approval for their blood-thinning drug Efient, also known as prasugrel.

Twitter
LinkedIn
Facebook
Email
Print

FDA Approvals

Eli Lilly and Company Daiichi Sankyo